Crown Prince announces medium-term debt strategy to diversify funding sources "A resilient economy capable of overcoming challenges reflects progress towards achieving Vision 2030 goals"    OPEC+ tripartite meeting keen on maintaining global oil market stability    'No excuses' for Israel to not accept ceasefire deal, EU foreign policy chief says    Riyadh Season draws 8 million visitors in 6 weeks    Alkhorayef highlights role of National Initiative for Global Supply Chains in boosting Saudi economy    Saudi Arabia signs investment deals worth SR35bn with foreign firms to strengthen global supply chains    Saudi Arabia unveils updates on Expo 2030 Riyadh master plan at 175th BIE General Assembly Riyadh Expo Development Company established to oversee strategic planning, operations, and legacy development    Saudi FM attends Quadripartite meeting on Sudan in Italy    Georgia's new parliament opens first session amid mass protests and boycott    Gangsters block aid distribution in south Gaza    Russian deserter reveals war secrets of guarding nuclear base    Best-selling novelist Barbara Taylor Bradford dies    Cristiano Ronaldo's double powers Al Nassr to 3-1 win over Al Gharafa in AFC Champions League    Saud Abdulhamid makes history as first Saudi player in Serie A    Al Ahli edges Al Ain 2-1, bolsters perfect start in AFC Champions League Elite    Al-Falih: 1,238 foreign investors obtain premium residency in Saudi Arabia    Most decorated Australian Olympian McKeon retires    Adele doesn't know when she'll perform again after tearful Vegas goodbye    'Pregnant' for 15 months: Inside the 'miracle' pregnancy scam    Do cigarettes belong in a museum?    Order vs. Morality: Lessons from New York's 1977 Blackout    India puts blockbuster Pakistani film on hold    The Vikings and the Islamic world    Filipino pilgrim's incredible evolution from an enemy of Islam to its staunch advocate    Exotic Taif Roses Simulation Performed at Taif Rose Festival    Asian shares mixed Tuesday    Weather Forecast for Tuesday    Saudi Tourism Authority Participates in Arabian Travel Market Exhibition in Dubai    Minister of Industry Announces 50 Investment Opportunities Worth over SAR 96 Billion in Machinery, Equipment Sector    HRH Crown Prince Offers Condolences to Crown Prince of Kuwait on Death of Sheikh Fawaz Salman Abdullah Al-Ali Al-Malek Al-Sabah    HRH Crown Prince Congratulates Santiago Peña on Winning Presidential Election in Paraguay    SDAIA Launches 1st Phase of 'Elevate Program' to Train 1,000 Women on Data, AI    41 Saudi Citizens and 171 Others from Brotherly and Friendly Countries Arrive in Saudi Arabia from Sudan    Saudi Arabia Hosts 1st Meeting of Arab Authorities Controlling Medicines    General Directorate of Narcotics Control Foils Attempt to Smuggle over 5 Million Amphetamine Pills    NAVI Javelins Crowned as Champions of Women's Counter-Strike: Global Offensive (CS:GO) Competitions    Saudi Karate Team Wins Four Medals in World Youth League Championship    Third Edition of FIFA Forward Program Kicks off in Riyadh    Evacuated from Sudan, 187 Nationals from Several Countries Arrive in Jeddah    SPA Documents Thajjud Prayer at Prophet's Mosque in Madinah    SFDA Recommends to Test Blood Sugar at Home Two or Three Hours after Meals    SFDA Offers Various Recommendations for Safe Food Frying    SFDA Provides Five Tips for Using Home Blood Pressure Monitor    SFDA: Instant Soup Contains Large Amounts of Salt    Mawani: New shipping service to connect Jubail Commercial Port to 11 global ports    Custodian of the Two Holy Mosques Delivers Speech to Pilgrims, Citizens, Residents and Muslims around the World    Sheikh Al-Issa in Arafah's Sermon: Allaah Blessed You by Making It Easy for You to Carry out This Obligation. Thus, Ensure Following the Guidance of Your Prophet    Custodian of the Two Holy Mosques addresses citizens and all Muslims on the occasion of the Holy month of Ramadan    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



EU medicines regulator approves Pfizer/BioNTech COVID-19 vaccine
Published in The Saudi Gazette on 21 - 12 - 2020

The European Medicines Agency (EMA) has recommended the use of the Pfizer-BioNTech COVID-19 vaccine in the European Union.
The authorization will pave the way for a possible start of vaccinations in Europe on Dec. 27.
After EMA scientists concluded that the vaccine is safe, officials at the Amsterdam-based agency recommended its conditional approval for it to be distributed across the 27-nation bloc.
The European Commission must still rubber-stamp the decision before the vaccine can be rolled out.
Head of the European Commission Ursula von der Leyen said the European Commission will now act fast and decide on the authorization tonight.
The pharmaceutical companies will also need to submit follow-up data on their vaccine for the next year.
In the press conference announcing the recommendation, Dr. Harald Enzmann, Chairman of the Committee for Medicinal Products for Human Use (CHMP) said the vaccine study offered an unusually large amount of data on how elderly people react to the vaccine.
More than 1,600 people over 75 took part in the study, which is highly unusual. In that group, the vaccine showed a 95 percent efficacy rate.
EMA, he said, has set the lower limit for vaccination at 16-year-olds.
Moreover, Enzmann said, there is not enough data on how pregnant women react to the vaccine. Thus, "we recommend a case by case decision" dependent on their exposure and risk, he noted. The number of pregnant women in the clinical study is "in the single digits," he added.
Moreover, he said it is still unclear whether those vaccinated may still be able to transmit the virus. Until there is more information with regards to transmission, he recommends that those who have successfully completed their vaccination to "please wear masks and keep your distance."
Sabine Straus, Chair of EMA's Safety Committee noted that more than 80,000 people have received the vaccine during the clinical study. The side effects that have been displayed are similar to those of other vaccines, such as pain at the injection site, tiredness, headache, muscle, and joint pain, or fever. Those symptoms usually last for a day.
Straus also pointed out that there have been very small numbers of allergic reactions to the vaccine. Based on these observations, people will now be closely observed for at least 15 minutes after getting the shot.
She added that generally, vaccines are only authorized if the benefits outweigh the risks, stressing that pharmaceutical companies will also have to send monthly updates about new findings. Usually, they only have to send those updates every six months.
EMA has also commissioned independent scientific studies to monitor the safety of the vaccine in its real-life application.
With regards to the newest strain of COVID-19 currently spreading across the UK and South Africa, the agency stated that this vaccine is likely to offer protection against the new variant.
The European regulator came under heavy pressure last week from countries calling for the vaccine to be granted approval for use as quickly as possible.
EMA had originally set December 29 as the date for its evaluation of the vaccine, made by Germany-based BioNTech, but moved the meeting forward after pressure from Berlin and other member states.
The EU's approval of the vaccine comes roughly three weeks after Britain, which has started administering the jab to its citizens. — Euro news


Clic here to read the story from its source.